资讯

Healio1 小时
GLP-1 use may prevent recurrent arrhythmia events for patients with diabetes, obesity
GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...
TCTMD2 小时
GLP-1 Drugs May Have Role in Secondary Prevention of AF
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
Medical Device Network7 小时
Abbott reports new data from study of PFA system for atrial fibrillation
Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...